AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit
Pathology International · 2026-07 · 76 (7)
DOI: 10.1111/pin.70145 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pathology International, online erschienen am 05.07.2026. Verfasst von Masashi Miyaoka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Tokai University, Isehara, Japan. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Proto-Oncogene Proteins c-bcl-2, Interferon Regulatory Factors. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Medicine, Tokai University, Isehara, Japan.
- Monoclonal Antibodies Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
ORCID-Profile: Joaquim Carreras, Shunsuke Nagase, Atsushi Ito, Naoya Nakamura
Zitieren
APA
Miyaoka, M., Carreras, J., Kikuti, Y. Y., Ikoma, H., Nagase, S., Ito, A., Orita, M., Tanigaki, Y., Masugi, Y., Roncador, G., & Nakamura, N. (2026). AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit. Pathology International, 76(7). https://doi.org/10.1111/pin.70145
Vancouver
Miyaoka M, Carreras J, Kikuti YY, Ikoma H, Nagase S, Ito A, et al. AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit. Pathology International. 2026;76(7). doi:10.1111/pin.70145
BibTeX
@article{Miyaoka2026,
author = {Miyaoka, Masashi and Carreras, Joaquim and Kikuti, Yara Yukie and Ikoma, Haruka and Nagase, Shunsuke and Ito, Atsushi and Orita, Makoto and Tanigaki, Yuki and Masugi, Yohei and Roncador, Giovanna and Nakamura, Naoya},
title = {AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B‐Cell Lymphoma/High‐Grade B‐Cell Lymphoma With Double‐Hit MYC and BCL2 or BCL6 and Triple Hit},
journal = {Pathology International},
year = {2026},
volume = {76},
number = {7},
doi = {10.1111/pin.70145}
}
EUVIMED